Pfizer PT Raised to $33.00 (PFE)
Research analysts at Jefferies Group upped their price objective on shares of Pfizer (NYSE:PFE) from $31.00 to $33.00 in a report released on Thursday, AR Network reports. The firm currently has a “hold” rating on the stock. Jefferies Group’s price objective points to a potential upside of 6.69% from the stock’s previous close.
A number of other firms have also recently commented on PFE. Analysts at Zacks reiterated a “neutral” rating on shares of Pfizer in a research note to investors on Tuesday. They now have a $32.00 price target on the stock. Separately, analysts at Cowen and Company cut their price target on shares of Pfizer from $37.00 to $34.00 in a research note to investors on Monday, December 30th. They now have an “outperform” rating on the stock. Finally, analysts at TheStreet reiterated a “buy” rating on shares of Pfizer in a research note to investors on Friday, December 20th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and eleven have issued a buy rating to the company. The company has an average rating of “Hold” and an average price target of $31.78.
Pfizer (NYSE:PFE) traded down 0.06% on Thursday, hitting $30.93. 20,579,740 shares of the company’s stock traded hands. Pfizer has a 52 week low of $26.34 and a 52 week high of $32.50. The stock’s 50-day moving average is $31.00 and its 200-day moving average is $29.65. The company has a market cap of $200.5 billion and a P/E ratio of 8.54.
Pfizer (NYSE:PFE) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $0.58 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.56 by $0.02. The company had revenue of $12.64 billion for the quarter, compared to the consensus estimate of $12.69 billion. During the same quarter last year, the company posted $0.53 earnings per share. Pfizer’s revenue was down 2.4% compared to the same quarter last year. Analysts expect that Pfizer will post $2.18 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, March 4th. Investors of record on Friday, February 7th will be given a dividend of 0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 3.36%. The ex-dividend date of this dividend is Wednesday, February 5th. This is an increase from Pfizer’s previous quarterly dividend of $0.24.
Pfizer Inc (NYSE:PFE) is a research-based, global biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.